Equities research analysts predict that MedEquities Realty Trust Inc (NYSE:MRT) will post $16.08 million in sales for the current quarter, according to Zacks. Three analysts have provided estimates for MedEquities Realty Trust’s earnings, with the lowest sales estimate coming in at $15.14 million and the highest estimate coming in at $16.79 million. MedEquities Realty Trust reported sales of $16.72 million in the same quarter last year, which indicates a negative year over year growth rate of 3.8%. The company is scheduled to issue its next quarterly earnings results on Thursday, May 16th.

On average, analysts expect that MedEquities Realty Trust will report full-year sales of $65.86 million for the current year, with estimates ranging from $62.16 million to $67.90 million. For the next financial year, analysts forecast that the business will report sales of $70.80 million, with estimates ranging from $70.29 million to $71.30 million. Zacks’ sales averages are an average based on a survey of research analysts that that provide coverage for MedEquities Realty Trust.

A number of research firms have weighed in on MRT. Zacks Investment Research upgraded MedEquities Realty Trust from a “strong sell” rating to a “hold” rating in a research report on Tuesday, January 22nd. ValuEngine downgraded MedEquities Realty Trust from a “buy” rating to a “hold” rating in a research report on Wednesday, February 13th. Finally, TheStreet upgraded MedEquities Realty Trust from a “d+” rating to a “c-” rating in a research report on Wednesday, January 16th. Ten investment analysts have rated the stock with a hold rating and one has given a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and an average price target of $10.89.

Shares of MRT stock traded up $0.05 on Friday, reaching $11.18. The company’s stock had a trading volume of 27,846 shares, compared to its average volume of 273,743. MedEquities Realty Trust has a 12-month low of $6.27 and a 12-month high of $11.85. The company has a market capitalization of $354.39 million, a PE ratio of 9.85 and a beta of 1.64.

Several institutional investors and hedge funds have recently added to or reduced their stakes in MRT. Chicago Capital Management LLC purchased a new position in shares of MedEquities Realty Trust in the first quarter worth about $21,810,000. Alpine Associates Management Inc. purchased a new position in shares of MedEquities Realty Trust in the first quarter worth about $17,385,000. Water Island Capital LLC purchased a new position in shares of MedEquities Realty Trust in the first quarter worth about $12,318,000. ARP Americas LP purchased a new position in shares of MedEquities Realty Trust in the first quarter worth about $12,165,000. Finally, Prudential Financial Inc. increased its holdings in shares of MedEquities Realty Trust by 41.0% in the fourth quarter. Prudential Financial Inc. now owns 2,603,235 shares of the financial services provider’s stock worth $17,806,000 after buying an additional 756,318 shares during the period. Hedge funds and other institutional investors own 94.48% of the company’s stock.

About MedEquities Realty Trust

MedEquities Realty Trust (NYSE: MRT) is a self-managed and self-administered real estate investment trust that invests in a diversified mix of healthcare properties and healthcare-related real estate debt investments. The Company's management team has extensive industry experience in acquiring, owning, developing, financing, operating, leasing and monetizing many types of healthcare properties and portfolios.

Featured Article: What is the NASDAQ?

Get a free copy of the Zacks research report on MedEquities Realty Trust (MRT)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for MedEquities Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedEquities Realty Trust and related companies with MarketBeat.com's FREE daily email newsletter.